Keros Therapeutics(KROS)
Focus: Keros Therapeutics is a public biotech focused on rare muscle disorders and rare diseases, headquartered in Lexington, MA with a lean operational footprint and early-stage pipeline.
Profile data last refreshed 3h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
7
Should You Work at Keros Therapeutics?
AI assessmentBest suited for early-career scientists seeking deep research immersion in rare disease biology with runway to see Phase 3 readouts in 2-3 years.
Why Work Here
- Heavy R&D investment ($174M in FY2025, doubled YoY) signals commitment to drug discovery and early-stage scientist roles
- Focused rare disease strategy offers deep scientific expertise development in underserved therapeutic areas
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$0K
Pipeline & Clinical Trials
KER-047
Iron Deficiency AnemiaClinical Trials (1)
NCT05927012A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).
Phase 2Help build intelligence for Keros Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.